A Massachusetts man is the only one in the country who has tried a nasal spray treatment for Alzheimer's. He's going to help ...

There’s another recall to be aware of right now, and it involves nose spray. NeilMed Pharmaceuticals Inc., the manufacturer ...

Retired electrician Joe Walsh in December became the first Alzheimer’s patient to try a nasal spray used to treat other ...

Jan. 27, 2025 – After years of limited options, people with hard-to-treat depression finally have a new standalone treatment. The FDA’s latest approval of the nasal spray Spravato (esketamine ...

Compared with placebo, zavegepant nasal spray yielded sustained relief of acute pain and function in migraine.

If you suffer from allergies or sinus congestion, you might want to think twice before using this nasal spray. The U.S. Food and Drug Administration is recalling 89,312 bottles of NasoGel nasal ...

The use of mouse models in this research has provided critical insights into the nasal spray’s effectiveness. These preclinical trials revealed not only a reduction in neuroinflammatory markers ...

Joe Walsh is now testing a new treatment using a nasal spray, the medication inside is called Foralumab. He is the first patient with Alzheimer's to try it. The Walsh family is hopeful. Foralumab is ...

STATEN ISLAND, N.Y. — The U.S. Food and Drug Administration (FDA) has announced a recall of 89,312 bottles of a popular nasal spray that may cause “adverse” effects. The NasoGel was recalled ...

The drug is designed to reduce inflammation in the brain and has been used on MS, cancer and migraine headaches.

The new FDA approval means people can use the nasal spray as-is to treat depression. Meaning, there's no need to take an oral antidepressant with it. That said, Spravato is a tightly controlled ...